
Teicoplanin is a potential inhibitor of SARS CoV-2 replication enzymes: A docking study
Author(s) -
Aatika Sadia,
Muhammad Azam,
Muhammad Asim Raza Basra
Publication year - 2020
Publication title -
asian pacific journal of tropical biomedicine/asian pacific journal of tropical biomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.507
H-Index - 61
eISSN - 2588-9222
pISSN - 2221-1691
DOI - 10.4103/2221-1691.294093
Subject(s) - dock , teicoplanin , docking (animal) , enzyme , pharmacology , in silico , antagonist , chemistry , receptor , biology , virology , vancomycin , medicine , biochemistry , bacteria , veterinary medicine , staphylococcus aureus , gene , genetics